Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake

University of Colorado Denver (CU Denver)

Status

Completed

Conditions

Primary Prevention

Treatments

Other: Control

Behavioral: Boot Camp Translation

Study type

Interventional

Funder types

Other

NIH

Identifiers

NCT04279964

18-0338

1R21CA230878-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.

Full description

As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs.

Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake.

Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates.

The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.

Enrollment

2,400 patients

Sex

All

Ages

9 to 26 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All child patients who have received health supervision at participating practices during the 12 month prior to intervention and the 12 month following intervention implementation, who are ages 9-26 years, and whose parents have not requested removal from the Colorado Immunization Information System (CIIS) will be eligible for the assessment of practice immunization rates in the pre and post periods.

Exclusion criteria

No subjects will be excluded because of gender, ethnicity, or insurance status.
Any child whose parents have requested removal from the immunization registry; any child with hypersensitivity to any component of one of the recommended vaccines; any child who has moved to a primary care provider other than one at the study clinics.